•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.CDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in Vitiligo
CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
CDT Highlights Sarborg's Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
CDT Equity Inc. Announces Reverse Stock Split
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
CDT Highlights Sarborg's Application of Signature Intelligence and Quantum Computing Models to Mental Health
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
CDT Environmental Technology Announces Results of Extraordinary General Meeting
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
CDT Equity Inc. Announces Reverse Stock Split
CDT Environmental Technology Investment Holdings Regains Compliance with Nasdaq Minimum Bid Price Requirement
CDT Environmental Technology Investment Holdings Limited to Hold Extraordinary General Meeting on July 28, 2026
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
CDT Equity Stock Gets A Boost On SarborgQ Development News